vs

Side-by-side financial comparison of CME Group (CME) and NXP Semiconductors (NXPI). Click either name above to swap in a different company.

NXP Semiconductors is the larger business by last-quarter revenue ($3.2B vs $1.9B, roughly 1.7× CME Group). NXP Semiconductors runs the higher net margin — 35.3% vs 0.1%, a 35.2% gap on every dollar of revenue. On growth, CME Group posted the faster year-over-year revenue change (14.5% vs -5.0%). Over the past eight quarters, CME Group's revenue compounded faster (10.8% CAGR vs 0.9%).

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

NXP Semiconductors N.V. is a Dutch semiconductor manufacturing and design company with headquarters in Eindhoven, Netherlands. It is the third largest European semiconductor company by market capitalization as of 2024. The company employs approximately 34,000 people in more than 30 countries and it reported revenues of $12.61 billion in 2024.

CME vs NXPI — Head-to-Head

Bigger by revenue
NXPI
NXPI
1.7× larger
NXPI
$3.2B
$1.9B
CME
Growing faster (revenue YoY)
CME
CME
+19.5% gap
CME
14.5%
-5.0%
NXPI
Higher net margin
NXPI
NXPI
35.2% more per $
NXPI
35.3%
0.1%
CME
Faster 2-yr revenue CAGR
CME
CME
Annualised
CME
10.8%
0.9%
NXPI

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CME
CME
NXPI
NXPI
Revenue
$1.9B
$3.2B
Net Profit
$1.2M
$1.1B
Gross Margin
59.5%
Operating Margin
0.1%
100.0%
Net Margin
0.1%
35.3%
Revenue YoY
14.5%
-5.0%
Net Profit YoY
20.7%
147.0%
EPS (diluted)
$4.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CME
CME
NXPI
NXPI
Q1 26
$1.9B
$3.2B
Q4 25
$1.6B
$3.3B
Q3 25
$1.5B
$3.2B
Q2 25
$1.7B
$2.9B
Q1 25
$1.6B
$2.8B
Q4 24
$1.5B
$3.1B
Q3 24
$1.6B
$3.3B
Q2 24
$1.5B
$3.1B
Net Profit
CME
CME
NXPI
NXPI
Q1 26
$1.2M
$1.1B
Q4 25
$1.2B
$455.0M
Q3 25
$908.0M
$631.0M
Q2 25
$1.0B
$445.0M
Q1 25
$956.2M
$490.0M
Q4 24
$874.6M
$495.0M
Q3 24
$912.8M
$718.0M
Q2 24
$883.2M
$658.0M
Gross Margin
CME
CME
NXPI
NXPI
Q1 26
59.5%
Q4 25
54.2%
Q3 25
56.3%
Q2 25
53.4%
Q1 25
55.0%
Q4 24
53.9%
Q3 24
57.4%
Q2 24
57.3%
Operating Margin
CME
CME
NXPI
NXPI
Q1 26
0.1%
100.0%
Q4 25
61.8%
22.3%
Q3 25
63.3%
28.1%
Q2 25
66.7%
23.5%
Q1 25
67.5%
25.5%
Q4 24
62.1%
21.7%
Q3 24
64.6%
30.5%
Q2 24
65.3%
28.7%
Net Margin
CME
CME
NXPI
NXPI
Q1 26
0.1%
35.3%
Q4 25
71.7%
13.6%
Q3 25
59.1%
19.9%
Q2 25
60.6%
15.2%
Q1 25
58.2%
17.3%
Q4 24
57.3%
15.9%
Q3 24
57.6%
22.1%
Q2 24
57.6%
21.0%
EPS (diluted)
CME
CME
NXPI
NXPI
Q1 26
$4.43
Q4 25
$3.24
$1.80
Q3 25
$2.49
$2.48
Q2 25
$2.81
$1.75
Q1 25
$2.62
$1.92
Q4 24
$2.40
$1.93
Q3 24
$2.50
$2.79
Q2 24
$2.42
$2.54

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CME
CME
NXPI
NXPI
Cash + ST InvestmentsLiquidity on hand
$2.4B
$3.7B
Total DebtLower is stronger
$3.4B
$11.7B
Stockholders' EquityBook value
$10.9B
Total Assets
$202.0B
$27.1B
Debt / EquityLower = less leverage
1.07×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CME
CME
NXPI
NXPI
Q1 26
$2.4B
$3.7B
Q4 25
$4.5B
$3.3B
Q3 25
$2.6B
$3.5B
Q2 25
$2.1B
$3.2B
Q1 25
$1.5B
$4.0B
Q4 24
$3.0B
$3.3B
Q3 24
$2.4B
$2.7B
Q2 24
$1.9B
$2.9B
Total Debt
CME
CME
NXPI
NXPI
Q1 26
$3.4B
$11.7B
Q4 25
$11.0B
Q3 25
$11.0B
Q2 25
$9.5B
Q1 25
$10.2B
Q4 24
$10.4B
Q3 24
$9.7B
Q2 24
$9.7B
Stockholders' Equity
CME
CME
NXPI
NXPI
Q1 26
$10.9B
Q4 25
$28.7B
$10.1B
Q3 25
$28.2B
$10.0B
Q2 25
$27.7B
$9.6B
Q1 25
$27.0B
$9.3B
Q4 24
$26.5B
$9.2B
Q3 24
$28.2B
$9.4B
Q2 24
$27.6B
$9.0B
Total Assets
CME
CME
NXPI
NXPI
Q1 26
$202.0B
$27.1B
Q4 25
$198.4B
$26.6B
Q3 25
$187.1B
$26.4B
Q2 25
$179.9B
$25.3B
Q1 25
$157.8B
$25.2B
Q4 24
$137.4B
$24.4B
Q3 24
$137.8B
$23.7B
Q2 24
$123.4B
$23.2B
Debt / Equity
CME
CME
NXPI
NXPI
Q1 26
1.07×
Q4 25
1.09×
Q3 25
1.09×
Q2 25
0.99×
Q1 25
1.10×
Q4 24
1.13×
Q3 24
1.03×
Q2 24
1.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CME
CME
NXPI
NXPI
Operating Cash FlowLast quarter
Free Cash FlowOCF − Capex
$714.0M
FCF MarginFCF / Revenue
22.4%
Capex IntensityCapex / Revenue
2.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$2.7B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CME
CME
NXPI
NXPI
Q1 26
Q4 25
$1.1B
$891.0M
Q3 25
$968.1M
$585.0M
Q2 25
$1.1B
$779.0M
Q1 25
$1.1B
$565.0M
Q4 24
$1.0B
$391.0M
Q3 24
$1.0B
$779.0M
Q2 24
$776.9M
$761.0M
Free Cash Flow
CME
CME
NXPI
NXPI
Q1 26
$714.0M
Q4 25
$1.1B
$793.0M
Q3 25
$949.7M
$508.0M
Q2 25
$1.0B
$696.0M
Q1 25
$1.1B
$426.0M
Q4 24
$991.7M
$261.0M
Q3 24
$973.2M
$593.0M
Q2 24
$758.7M
$576.0M
FCF Margin
CME
CME
NXPI
NXPI
Q1 26
22.4%
Q4 25
66.8%
23.8%
Q3 25
61.8%
16.0%
Q2 25
61.5%
23.8%
Q1 25
67.1%
15.0%
Q4 24
65.0%
8.4%
Q3 24
61.4%
18.2%
Q2 24
49.5%
18.4%
Capex Intensity
CME
CME
NXPI
NXPI
Q1 26
2.5%
Q4 25
2.0%
2.9%
Q3 25
1.2%
2.4%
Q2 25
1.1%
2.8%
Q1 25
0.9%
4.9%
Q4 24
1.7%
4.2%
Q3 24
1.9%
5.7%
Q2 24
1.2%
5.9%
Cash Conversion
CME
CME
NXPI
NXPI
Q1 26
Q4 25
0.96×
1.96×
Q3 25
1.07×
0.93×
Q2 25
1.03×
1.75×
Q1 25
1.17×
1.15×
Q4 24
1.16×
0.79×
Q3 24
1.10×
1.08×
Q2 24
0.88×
1.16×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons